JUVENA THERAPEUTICS
JUVENA THERAPEUTICS logo

Juvena Therapeutics is a computationally-driven biopharmaceutical company on a mission to develop disease-modifying biologics to treat chronic muscle and metabolic diseases. The company’s approach stems from unlocking the therapeutic potential of stem-cell secreted proteins and translating them into a growing pipeline of engineered biologics. In addition to JUV-161, Juvena is progressing multiple preclinical programs, including a novel obesity asset with a unique mechanism. Juvena is achieving this through a fully integrated, end-to-end Artificial Intelligence (AI)-enabled drug discovery and development platform that combines a compounding database mapping secreted proteins to specific disease phenotypes, in silico and in vitro human cell screening, pharmacology, and protein engineering capabilities.

Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.

© 2023-24 DxMultiomics. All rights reserved.